Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Roche overhauls Spark gene therapy unit, recording $2.4B in full impairment
Fierce Pharma
Monday, March 10, 2025 - 11:20pm
tags:
Roche, Spark Therapeutics, gene therapy, restructuring
Beam base editing therapy gets ‘proof of concept’ in rare lung disease
BioPharma Dive
Monday, March 10, 2025 - 11:17pm
tags:
Beam Therapeutics, base editing, alpha-1 antitrypsin deficiency, CRISPR
Off-label use of semaglutide and tirzepatide shows promise in type 1 diabetes
Clinical Trials Arena
Monday, March 10, 2025 - 11:13pm
tags:
type 1 diabetes, semaglutide, tirzepatide
Emergent BioSolutions to sell Baltimore-Bayview manufacturing site for $36.5M
MSN/Seeking Alpha
Monday, March 10, 2025 - 11:11pm
tags:
Emergent BioSolutions, Baltimore, drug manufacturing, CDMO, Syngene International
Eli Lilly plans launch of weight-loss drug in emerging markets in 2025, CFO says
MSN/Reuters
Monday, March 10, 2025 - 11:09pm
tags:
Eli Lilly, Mounjaro, China, India, Mexico, Brazil, emerging markets
J&J opts out of licensing Genmab's Darzalex challenger after look at phase 1/2 data
Fierce Biotech
Monday, March 10, 2025 - 11:06pm
tags:
JNJ, Genmab, monoclonal antibodies, Darzalex
On the heels of FDA nod for cancer drug, Sun Pharma buys Checkpoint Therapeutics for up to $416M
Fierce Pharma
Monday, March 10, 2025 - 11:15am
tags:
Sun Pharma, Checkpoint Therapeutics, M&A, Unloxcyt
Novo Nordisk's Ozempic successor disappointed Wall Street again
Yahoo Finance
Monday, March 10, 2025 - 11:13am
tags:
Novo Nordisk, obesity, CagriSema, clinical trials
Mineralys shares climb on study data for blood pressure drug
BioPharma Dive
Monday, March 10, 2025 - 11:12am
tags:
Mineralys Therapeutics, hypertension, clinical trials, lorundrosta
As Walgreens Preps For New Owner, CVS Health Tries Smaller Drugstores
Forbes
Monday, March 10, 2025 - 11:10am
tags:
pharmacies, CVS Health, Walgreens
AstraZeneca reports positive outcomes from trial of Imfinzi
Clinical Trials Arena
Monday, March 10, 2025 - 11:05am
tags:
AstraZeneca, clinical trials, Imfinzi, gastric cancer, gastroesophageal cancer
BioNTech Surpasses Q4 Revenue Estimates
Motley Fool
Monday, March 10, 2025 - 10:00am
tags:
BioNTech, earnings
Amgen and Kyowa Kirin’s rocatinlimab trial for atopic dermatitis meets endpoints
Clinical Trials Arena
Monday, March 10, 2025 - 9:34am
tags:
Amgen, Kyowa Kirin, clinical trials, rocatinlimab, atopic dermatitis
Trial results enhance Bristol Myers' bid for Sotyktu in psoriatic arthritis
Fierce Pharma
Monday, March 10, 2025 - 9:33am
tags:
Bristol Myers Squibb, Sotyktu, psoriatic arthritis, clinical trials
Bayer CEO Bill Anderson took pay cut in 2024 as company kicked off 3-year restructuring
Fierce Pharma
Monday, March 10, 2025 - 9:32am
tags:
Bayer, Pharma CEOs, Bill Anderson, executive compensation
The Evolution of Medical Sales: What’s Changing in 2025?
CP Wire
Monday, March 10, 2025 - 9:30am
tags:
pharma sales, artificial intelligence, regulatory, drug pricing, Donald Trump, vaccines
Novo Nordisk welcomes patients to the Ozempic Era
Medical Marketing and Media
Monday, March 10, 2025 - 9:29am
tags:
Novo Nordisk, Ozempic, Wegovy, pharma marketing, DTC advertising
What’s driving pharma’s layoffs in 2025
Pharma Voice
Monday, March 10, 2025 - 9:27am
tags:
layoffs, CRISPR Therapeutics, Galapagos, Atara Biotherapeutics, Bristol Myers Squibb, Eisai, Biogen
J&J shows its confidence in oral IL-23 drug for psoriasis
Pharmaphorum
Monday, March 10, 2025 - 9:25am
tags:
JNJ, icotrokinra, psoriasis, Stelara, clinical trials
J&J axes late-stage depression trial after underwhelming efficacy
BioSpace
Friday, March 7, 2025 - 11:30am
tags:
JNJ, clinical trials, depression, aticaprant, Intra-Cellular Therapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.